Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma

BACKGROUND: There are limited treatment options available for patients with advanced pancreatic ductal adenocarcinoma (PDAC). We conducted a phase II study evaluating the efficacy and safety of capecitabine/oxaliplatin (CAPOX) in patients with locally advanced and metastatic PDAC treated in the firs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Oncol
Main Authors: Bullock, Andrea, Stuart, Keith, Jacobus, Susanna, Abrams, Thomas, Wadlow, Raymond, Goldstein, Michael, Miksad, Rebecca
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750180/
https://ncbi.nlm.nih.gov/pubmed/29299353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados